Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
clinical trials
life sciences
4
×
national blog main
4
×
new york blog main
san francisco blog main
boston blog main
boston top stories
national top stories
new york top stories
san francisco top stories
biotech ipos
boston
fda
rare disease drugs
acute migrane
acute myeloid leukemia
aligos therapeutics
alx oncology
astellas pharma
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
bain capital
baker brothers life sciences
bausch health
benzodiazepine
berkeley lights
blackstone group
blepharitis
bluebird bio
breast cancer
cancer drugs
cancer immunotherapy
cavion
cd47
cephalgia
chronic hepatitis b virus
chronic kidney disease
What
ipos
4
×
ipo
biotech
biotechs
companies
days
drug
hasn’t
medicines
prep
research
slowed
activity
ago
arrival
central
cns
considering
data
diseases
disorder
dog
drugs
dyne
early
emerged
expected
experimental
eyes
firm
genetic
having
humans
industry
kept
leading
leads
life
line
long
Language
unset
4
×
Current search:
ipos
×
photo
×
" national blog main "
×
" life sciences "
×
unset
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs